Stephan BeckPhD, FMedSci
Dr. Beck is Professor of Medical Genomics at the University College London (UCL) Cancer Institute. Using experimental and computational approaches, his laboratory has broad interests in the genomics and epigenomics of phenotypic plasticity in health and disease. He has over 30 years experience in high-throughput genomics and has co-authored over 250 publications that have attracted over 40,000 citations to date. He received his PhD in 1985 from the University of Konstanz where he studied DNA structure.
After appointments at the MRC Laboratory of Molecular Biology in Cambridge, Millipore Corporation in Boston and the Imperial Cancer Research Fund in London, he joined the Wellcome Trust Sanger Institute in 1996. During his tenure as Head of Human Sequencing (1998-2006), he played a leading role in the sequencing and analysis of the human, mouse and zebrafish genomes. He has co-founded and led a number of international efforts, including the Human Epigenome Project and serves on numerous national and international advisory boards. He is a Fellow of the Academy of Medical Sciences and recipient of a Royal Society Wolfson Research Merit Award.